NCT03871972View on ClinicalTrials.gov

Umbilical Cord Blood Transfusion in Progeria Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 5, 2019

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Hutchinson-Gilford Progeria Syndrome
Interventions
DRUG

Umbilical Cord Blood Unit

3 infusions of umbilical cord blood (UCB) unit (TNC \> 2.0ⅹ107cells/kg) each 4 months apart and take oral Sirolimus (1 mg/m2/day) for 7 days (from 3 days before UCB infusion until 3 days after UCB infusion)

Trial Locations (1)

13496

Bundang CHA Medical Center, Seongnam-si

All Listed Sponsors
lead

Bundang CHA Hospital

OTHER

NCT03871972 - Umbilical Cord Blood Transfusion in Progeria Syndrome | Biotech Hunter | Biotech Hunter